{
  "openalex_id": "W2892827065",
  "doi": "https://doi.org/10.1182/blood-2018-08-867036",
  "title": "Higher-risk APS: do we dare to DOAC?",
  "abstract": "",
  "authors": [
    {
      "display_name": "Marissa Laureano",
      "id": "A5090326758",
      "orcid": "https://orcid.org/0000-0002-8463-3192",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Marissa Laureano"
    },
    {
      "display_name": "Mark Crowther",
      "id": "A5079941141",
      "orcid": "https://orcid.org/0000-0003-4986-4873",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mark A. Crowther"
    }
  ],
  "publication_year": 2018,
  "publication_date": "2018-09-27",
  "type": "letter",
  "cited_by_count": 9,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S200071133",
    "display_name": "Blood",
    "issn_l": "0006-4971",
    "issn": [
      "0006-4971",
      "1528-0020"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320990"
  },
  "volume": "132",
  "issue": "13",
  "first_page": "1357",
  "last_page": "1358",
  "open_access": {
    "is_oa": true,
    "oa_status": "bronze",
    "oa_url": "https://ashpublications.org/blood/article-pdf/132/13/1357/1467205/blood867036.pdf",
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2778661090",
      "display_name": "Rivaroxaban",
      "level": 4,
      "score": 0.94397366
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.7228903
    },
    {
      "id": "C2776874634",
      "display_name": "Antiphospholipid syndrome",
      "level": 3,
      "score": 0.65778744
    },
    {
      "id": "C2776301958",
      "display_name": "Warfarin",
      "level": 3,
      "score": 0.62400424
    },
    {
      "id": "C168563851",
      "display_name": "Randomized controlled trial",
      "level": 2,
      "score": 0.46786192
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.43744445
    },
    {
      "id": "C2779161974",
      "display_name": "Atrial fibrillation",
      "level": 2,
      "score": 0.25626087
    },
    {
      "id": "C2780868729",
      "display_name": "Thrombosis",
      "level": 2,
      "score": 0.24902165
    }
  ],
  "topics": [
    {
      "id": "T10308",
      "display_name": "Systemic Lupus Erythematosus Research",
      "score": 0.9996
    },
    {
      "id": "T12352",
      "display_name": "Heparin-Induced Thrombocytopenia and Thrombosis",
      "score": 0.9995
    },
    {
      "id": "T10285",
      "display_name": "Venous Thromboembolism Diagnosis and Management",
      "score": 0.9985
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1182/blood-2018-08-867036",
  "pdf_url": "https://ashpublications.org/blood/article-pdf/132/13/1357/1467205/blood867036.pdf",
  "retrieved_date": "2025-07-30T14:30:20.971246",
  "source_database": "OpenAlex"
}